Skip to main content
Clinical Trials/CTRI/2025/03/083606
CTRI/2025/03/083606CompletedPhase 2

A comparative clinical study for efficacy of Lodhradi gel and High-Frequency treatment in management of yuvanpidika

National Institute of Ayurveda Deemed to be university, Jaipur1 site in 1 country30 target enrollmentStarted: March 30, 2025Last updated:

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
Change in Total Lesion Count -Reduction in the total number of Acne lesions Pidika(inflammatory and non-inflammatory ) from baseline to specified follow up period.

Study Overview

Brief Summary

In Ayurvedic literature, the use of Lodhradi Lepa (Shusruta Samhita, Chikitsa Sthana 20/38**)** is mentioned for the treatment of Yuvanpidika (acne vulgaris). However, in today’s lifestyle, the process of daily application, waiting for it to partially dry, and then washing it off can be time consuming and somewhat inconvenient. Transforming the same formulation into a gel would provide a more convenient and user-friendly alternative.High-Frequency treatment demonstrated a microbicidal effect on skin flora and pathogens in vitro with a significant decrease in bacterial and fungal counts after a short treatment period.

RESEARCH QUESTION:Whether there is any difference in clinical efficacy of Lodhradi Gel and High-Frequency treatment in management of Yuvanpidika?

STUDY DESIGN- the study consists of 3 groups with 10 patients in each group.

Group A - We are giving Lodhradi gel as topical application once in a day for 1 month.

Group B - We are giving High-Frequency treatment to patients for 8 minutes once a week for 1 month.

Group C - We are giving Lodhradi gel + High-Frequency treatment for 8 minutes once a week for 1 month

ASSESMENT: Assessment will be done on basis of Scoring pattern for symptoms of Yuvanpidikaand IGA scale for acne vulgaris.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 35.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients of Yuvanpidika age groups 18-35 years of either gender.
  • Patients having cardinal symptoms of the disease like Pidika on face including Ruja, Daha, Paka, Srava of Yuvanpidika mentioned in Ayurveda and modern literature features of acne vulgaris like Papules, Pustules, Black & White head, Itching, Redness & Inflammation around eruption.
  • Distribution of Yuvanpidika on Forehead, Cheeks, Nose & Chin.

Exclusion Criteria

  • Diagnosed Patient with Carcinoma, Burns, Herpes, Eczema, Psoriasis, Measles, Chickenpox, Leukoderma and Leprosy.
  • Patients with known case of common systemic diseases like T.B. Diabetes, AIDS, and Leprosy.

Outcomes

Primary Outcomes

Change in Total Lesion Count -Reduction in the total number of Acne lesions Pidika(inflammatory and non-inflammatory ) from baseline to specified follow up period.

Time Frame: 1 month

Secondary Outcomes

  • Severity of Acne: Assessed using validated scales for classical symptoms and IGA (Investigator’s global assessment) scale(Adverse Events-Monitoring and documenting any side effects or complications arising from)

Investigators

Sponsor
National Institute of Ayurveda Deemed to be university, Jaipur
Sponsor Class
Other [Government medical college]
Responsible Party
Principal Investigator
Principal Investigator

Dr Shreya Arya

National Institute of Ayurveda, jaipur

Study Sites (1)

Loading locations...

Similar Trials